Farms.com Home   News

Pushback on USDA's electronic tagging for livestock

Oct 01, 2024
By Farms.com

Congress called to act against livestock E-Tag rule

 

A coalition of 46 farming, ranching, and food groups, led by R-CALF USA, is pressing Congress to block an impending USDA rule mandating electronic ear tags for adult cattle and bison crossing state lines. This rule, effective from November 2024, modifies the existing Animal Disease Traceability (ADT) protocol, which many believe is sufficiently effective.

The mandated electronic identification (EID) has been criticized for potentially burdening smaller producers and consolidating the food supply chain under major meatpacking firms, thus threatening national food security.

Opponents contend the rule is less about animal health and more about profit margins for multinational corporations and technology firms involved in the production of tagging systems.

This initiative has sparked significant backlash, with claims that it would cover only 11% of cattle in the event of a disease outbreak, casting doubts on its overall utility.

Groups are rallying behind legislation such as H.J.Res.167, S.J.Res.98, and S.4282 to counteract the mandate, with considerable support already mounting in the House.

Bill Bullard, CEO of R-CALF USA, highlights the extensive opposition from producers and stresses the importance of congressional action to prevent the potentially detrimental impact of this rule on the livelihoods of American ranchers and farmers.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.